We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27.8B
AUM Growth
+$3.36B
(+14%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
55.63%
Holding
2,156
New
217
Increased
776
Reduced
764
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$157M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$117M |
| 3 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$105M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$94M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$93.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mid-Cap ETF
VO
|
+$63.3M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$32.3M |
| 3 |
Schwab US REIT ETF
SCHH
|
+$21.3M |
| 4 |
Vanguard Energy ETF
VDE
|
+$18.8M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.74% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 2.19% |
| 4 | Energy | 2.03% |
| 5 | Consumer Discretionary | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $790K | ﹤0.01% |
16,296
+158
| +1% | +$7.63K |
|
|
BLUE
827
DELISTED
bluebird bio
BLUE
| $787K | ﹤0.01% |
386
-17
| -4% | -$29.9K |
|
828
Citizens Financial Group
CFG
$30.4B
| $781K | ﹤0.01% |
24,038
+1,272
| +6% | +$44.1K |
|
829
Dell
DELL
$283B
| $781K | ﹤0.01% |
+26,263
| New | +$692K |
|
830
UBS Group
UBS
$170B
| $781K | ﹤0.01% |
64,504
-2,603
| -4% | -$33K |
|
831
Cencora
COR
$60.3B
| $779K | ﹤0.01% |
9,798
+994
| +11% | +$79.9K |
|
832
Trex
TREX
$4.51B
| $778K | ﹤0.01% |
25,290
-17,534
| -41% | -$613K |
|
833
Cheniere Energy
CQP
$31.8B
| $776K | ﹤0.01% |
18,516
+1,156
| +7% | +$47.7K |
|
834
Howard Hughes
HHH
$3.93B
| $776K | ﹤0.01% |
7,395
-75
| -1% | -$7.77K |
|
835
Takeda Pharmaceutical
TAK
$55.1B
| $771K | ﹤0.01% |
+37,830
| New | +$761K |
|
836
Wheaton Precious Metals
WPM
$50.6B
| $771K | ﹤0.01% |
32,386
-3,410
| -10% | -$72.5K |
|
837
W.R. Berkley
WRB
$28B
| $769K | ﹤0.01% |
30,655
-1,681
| -5% | -$39.6K |
|
838
Magna International
MGA
$17.9B
| $767K | ﹤0.01% |
15,743
+71
| +0.5% | +$3.58K |
|
839
National Grid
NGG
$82.7B
| $767K | ﹤0.01% |
15,529
-3,127
| -17% | -$151K |
|
840
Vanguard FTSE Europe ETF
VGK
$30B
| $767K | ﹤0.01% |
14,311
-52
| -0.4% | -$2.72K |
|
841
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
| $766K | ﹤0.01% |
24,943
-2,835
| -10% | -$86.7K |
|
842
Bank of Montreal
BMO
$125B
| $765K | ﹤0.01% |
10,220
-1,163
| -10% | -$86K |
|
843
Boston Properties
BXP
$11B
| $765K | ﹤0.01% |
5,713
+5
| +0.1% | +$642 |
|
844
CarMax
KMX
$8.27B
| $764K | ﹤0.01% |
10,943
-1
| -0% | -$62 |
|
845
York Water
YORW
$505M
| $759K | ﹤0.01% |
22,126
| – | – |
|
846
NetApp
NTAP
$32.9B
| $757K | ﹤0.01% |
10,918
+2,966
| +37% | +$191K |
|
847
Cornerstone Strategic Value Fund
CLM
$2.17B
| $753K | ﹤0.01% |
62,812
-13,509
| -18% | -$161K |
|
848
Zevra Therapeutics
ZVRA
$563M
| $752K | ﹤0.01% |
28,132
| – | – |
|
849
Invesco Mortgage Capital
IVR
$776M
| $751K | ﹤0.01% |
4,756
-990
| -17% | -$157K |
|
850
Oshkosh
OSK
$9.67B
| $748K | ﹤0.01% |
9,951
+18
| +0.2% | +$1.33K |
|
Similar funds
Creative Planning's Q1 2019 Portfolio in Review
As of Q1 2019, Creative Planning held 2,156 positions worth $27.8B, up 14% from $24.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Creative Planning's Q1 2019 filing shows 217 new, 776 increased, 764 reduced and 175 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M. The largest sale was Vanguard Mid-Cap ETF, an estimated $63.3M.
By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 5.2% a quarter earlier, followed by Technology and Healthcare.
- Creative Planning's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q1 2019, an estimated $157M increase.
- Creative Planning's biggest Q1 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $63.3M.
- Creative Planning fully exited Kforce in Q1 2019, selling an estimated $3.23M.
- Creative Planning's ten largest holdings make up 56% of its $27.8B portfolio in Q1 2019.
- Creative Planning opened 217 new positions and closed 175 in Q1 2019.
- Creative Planning's portfolio value rose 14% quarter-over-quarter to $27.8B.
Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.